Efficacy and Safety of BC-819 and Gemcitabine in Patients With Locally Advanced Pancreatic Adenocarcinoma

NCT01413087 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
12
Enrollment
INDUSTRY
Sponsor class

Stopped Due to Sponsor's decision, only 12 patients were randomized \& completed study.

Conditions

Interventions

Sponsor

Anchiano Therapeutics Israel Ltd.